Products and Services
Take2 Clarity™ Test for NPC Monitoring
Better prediction of NPC recurrence is crucial to both patients and doctors. The Take2 Clarity™ Test utilises the Next-generation Sequencing (NGS) analysis that allows a more comprehensive, unbiased detection and quantitation of plasma EBV DNA. Through blood drawing, it provides robust and clinically proven assay performance in the prognostication of NPC patients after treatment.